![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
Robert Collins, MD
Director of the Hematologic Malignancies and Cellular Therapy Program
Specialities: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasm
Spoken languages: English
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
more_vert
/
/
/
Robert Collins
Clinical Expertise
- Acute Myeloid Leukemia (AML)
- Aplastic Anemia
- Myelodysplastic Syndromes (MDS)
- Myeloproliferative Neoplasms (MPN)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
About
Leukemia patients, including those who require lifesaving bone marrow transplants, have more treatment options than ever, says hematologist/oncologist Robert Collins Jr., M.D., FACP.
“We are completely dedicated to giving our patients the best possible care." – Dr. Robert Collins Jr., M.D., FACP
A specialist in leukemia, lymphoma, and cellular therapy, including stem cell transplantation and CAR T-cell therapy, Dr. Collins is Director of the Hematologic Malignancies and Cellular Therapy Program and the Combined Adult/Pediatric Stem Cell Transplant Program at UT Southwestern Medical Center.
“The fields are just exploding – from our understanding of their scientific underpinnings to the therapies we can offer patients – and it’s only getting better,” he says.
Dr. Collins treats patients with all types of leukemia – from the most common and straightforward cases to the rarest and most complex, as well as those with other hematologic malignancies and bone marrow diseases, including lymphoma, myelodysplastic syndrome, and aplastic anemia.
A noted expert in his field, Dr. Collins has, since the late 1980s, helped to develop the treatment known as adoptive immunotherapy, which involves manipulating a donor’s immune system so that it attacks cancer cells. He has led an international network in studies of adoptive immunotherapy, and he applies the approach daily in his clinical practice.
More recently, Dr. Collins has been involved in the development of new molecular-targeted therapies for leukemia, based on recent insights into the biology of the disease.
From caring for patients to conducting research, Dr. Collins finds all aspects of his work gratifying.
“It’s incredibly inspiring to see the dignity with which the patients face their illnesses,” he says. “It’s an honor to be able to work side-by-side with them to come up with the best possible approaches to their diseases.”
As the leader of two treatment programs, Dr. Collins is proud that UT Southwestern offers the best care in the area for patients with leukemia, lymphoma, and myeloma.
“We have a team of highly talented, dedicated people in a highly complicated field, and I'm proud of the work we do here every day.”
Location
Harold C. Simmons Comprehensive Cancer Center - UT Southwestern: 5323 Harry Hines Blvd, Dallas, TX 75390, USA
Get the Latest Leukemia Updates, Delivered to You.
By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Together we care.
Together we cure.
3x Faster.
Join our year-end match and help us reach $2 million for blood cancer research!